0 items
Your cart is empty.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
99.2% On-Time Delivery
Tracked International Shipping
Refund Within 28 Days
Secure, Encrypted Checkout
$52.00
This product is available by prescription only
This product does not require a prescription
Out Of Stock
Each peptide batch is tested and verified to meet or exceed 98–99% purity (HPLC).
Store 2–8 °C (≤–20 °C long-term). RT exposure during transport acceptable. Protect from light.
The product is delivered in powdered (lyophilized) form and must be properly reconstituted prior to research use.
This synthetic research peptide formulation provides laboratories with a standardized GHRH analog compound for experimental studies. The compact 5mg format supports controlled research applications in qualified laboratory settings. Each batch undergoes rigorous purity verification to ensure consistency across research protocols. High-purity formulation meets research-grade standards for GHRH peptide investigations. Secure packaging protects compound integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.
Researchers investigate Sermorelin within controlled laboratory environments to examine GHRH analog structure and mechanisms. Experimental models utilize this compound to study growth hormone-releasing hormone characteristics in vitro. Controlled laboratory peptide stability studies assess compound properties under standardized experimental conditions. Scientists explore GHRH peptide structures in research settings. Laboratory personnel examine peptide behavior in experimental models designed for hormone analog research. These investigations occur exclusively in controlled research environments without clinical applications.
Sermorelin is investigated in research environments to understand GHRH analog mechanisms. This compound is studied within controlled laboratory models examining growth hormone-releasing hormone properties. Researchers explore this peptide for experimental peptide research applications in academic and institutional settings. Laboratory studies examine the compound’s structural characteristics under standardized protocols. Scientists investigate molecular properties relevant to GHRH research methodologies. All research applications remain confined to laboratory environments and experimental frameworks.
Store Sermorelin at 2-8°C for optimal stability. Storage temperature should remain consistent to maintain compound integrity. Keep the product sealed until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in peptide research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling this research compound. Reconstitution should follow standard laboratory peptide preparation procedures using sterile techniques. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.
Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound purity at 99%+ by HPLC analysis. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification results. Internal quality assurance standards maintain strict compound specifications. Testing procedures verify molecular weight, purity percentage, amino acid sequence, and compound identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.
Sermorelin is a synthetic GHRH analog peptide compound produced for research applications. A GHRH analog is a modified version of growth hormone-releasing hormone. This peptide consists of 29 amino acids representing the active fragment of natural GHRH. The compound is designated as GHRH(1-29) in research literature. Scientists study GHRH analogs to understand hormone structure-activity relationships. This synthetic peptide origin ensures batch-to-batch consistency for research protocols. The compound represents the bioactive N-terminal portion of the natural hormone. Researchers examine this peptide’s properties within controlled laboratory conditions without therapeutic context.
Novera Research delivers high-quality research peptides developed under strict manufacturing and quality-control standards. Each product is carefully synthesized, tested, and handled to ensure consistency, reliability, and transparency for advanced research applications.
High-purity, research-grade peptide synthesis
Analytical testing to verify quality and composition
Consistent batch-to-batch performance
Batch identification on every vial for traceability
Stored and shipped under controlled conditions
Research-grade dual-peptide blend combining short-acting synthetic peptides for flexible laboratory research protocols.
A synthetic aromatic-cationic tetrapeptide studied for selective inner mitochondrial membrane localization, cardiolipin binding dynamics, and oxidative phosphorylation pathway marker activity in controlled in-vitro and preclinical models.
Research-grade triple-peptide formulation offering comprehensive multi-compound analysis capabilities for advanced laboratory research protocols.
Research-grade dual-peptide formulation combining two synthetic peptides for streamlined laboratory peptide research protocols.
Research-grade synthetic dual-peptide formulation combining amylin analog and GLP-1 receptor agonist for dual-mechanism pathway studies and combination peptide research in controlled laboratory environments.
